Skip to content

Drug interactions

Mavacamten + Telmisartan

Severity: Minor

Mavacamten and Telmisartan: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Telmisartan is not an established CYP2C19 inhibitor, so a meaningful rise in mavacamten levels is unlikely. Mavacamten itself requires careful monitoring of ejection fraction.

What this interaction means in plain words

Mavacamten and Telmisartan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Mavacamten belongs to Cardiovascular; Telmisartan belongs to Cardiovascular.

Evidence level: Low

Why it happens

Weak, theoretical CYP2C19 inhibition by telmisartan; not clinically established.

What to do

No dose change is needed; follow standard mavacamten echocardiographic monitoring.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mavacamten and Telmisartan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Mavacamten with Telmisartan?

MediHelp rates the interaction as minor. Mavacamten and Telmisartan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Telmisartan is not an established CYP2C19 inhibitor, so a meaningful rise in mavacamten levels is unlikely. Mavacamten itself requires careful monitoring of ejection fraction.

How serious is the interaction between Mavacamten and Telmisartan?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is needed; follow standard mavacamten echocardiographic monitoring.

What other medicines interact with Telmisartan?

MediHelp also lists interactions of Telmisartan with, for example, Aliskiren, Sparsentan, Amifostine. The full list is on the Telmisartan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in